Free Trial

Addus HomeCare (NASDAQ:ADUS) Reaches New 12-Month High at $136.12

Addus HomeCare logo with Medical background

Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) shares reached a new 52-week high on Wednesday . The stock traded as high as $136.12 and last traded at $135.09, with a volume of 63665 shares traded. The stock had previously closed at $132.47.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Stephens reaffirmed an "overweight" rating and set a $138.00 price objective on shares of Addus HomeCare in a research note on Tuesday, August 6th. TD Cowen raised their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a "buy" rating in a research report on Thursday, August 8th. Royal Bank of Canada reissued an "outperform" rating and issued a $141.00 target price on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Macquarie began coverage on shares of Addus HomeCare in a research note on Friday, June 28th. They issued an "outperform" rating and a $136.00 price objective for the company. Finally, StockNews.com downgraded shares of Addus HomeCare from a "strong-buy" rating to a "buy" rating in a research report on Sunday, July 7th. One investment analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company. According to data from MarketBeat, Addus HomeCare currently has a consensus rating of "Moderate Buy" and a consensus target price of $127.57.

View Our Latest Stock Analysis on Addus HomeCare

Addus HomeCare Price Performance

The company has a market capitalization of $2.40 billion, a P/E ratio of 32.87, a PEG ratio of 2.33 and a beta of 1.04. The stock's fifty day simple moving average is $126.34 and its 200-day simple moving average is $113.55.


Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.14. The firm had revenue of $286.90 million during the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.94 EPS. On average, research analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Insider Activity

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the company's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, Director Esteban Lopez sold 500 shares of the business's stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares of the company's stock, valued at approximately $429,165. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares of the company's stock, valued at $961,687.35. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 22,917 shares of company stock worth $3,050,082. Company insiders own 4.60% of the company's stock.

Hedge Funds Weigh In On Addus HomeCare

Large investors have recently modified their holdings of the business. Texas Permanent School Fund Corp increased its holdings in shares of Addus HomeCare by 0.6% during the 2nd quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company's stock worth $1,636,000 after acquiring an additional 82 shares during the last quarter. Arizona State Retirement System grew its position in Addus HomeCare by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company's stock worth $527,000 after acquiring an additional 87 shares during the last quarter. UMB Bank n.a. increased its stake in shares of Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company's stock valued at $26,000 after buying an additional 88 shares during the period. Azzad Asset Management Inc. ADV raised its stake in shares of Addus HomeCare by 1.3% during the second quarter. Azzad Asset Management Inc. ADV now owns 8,436 shares of the company's stock valued at $980,000 after acquiring an additional 110 shares during the last quarter. Finally, Guinness Asset Management LTD lifted its holdings in Addus HomeCare by 3.3% during the 2nd quarter. Guinness Asset Management LTD now owns 5,001 shares of the company's stock worth $580,000 after buying an additional 158 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Addus HomeCare right now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Rate Cuts Fuel Volatility: How Long Could it Last?
SMCI Stock: Is a Rebound Coming?
FOMC’s Rate Cut Decision Could Drive Market Swings

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines